Avid Bioservices Inc (CDMO)

[investingdog]

<< What do you think the value of pphm will be if the FDA approves Bavi for ph III 2nd line lung, 1st line comes in at 15-20 months MOS, Bavi 2nd line is partnered, liver is partnered, pancreatic results based on subgroup ( or just similar ECOG) shows a better than Abraxane MOS (combination with Abrax to follow), etc? >>

This would be the best case scenario, north of 10 bucks with a potential to go much higher toward the end of p3 trials.

Let's look at the worst case now:
FDA doesn't approve p3 and wants another p2. First line comes in at 10 months or less and pancreatic subgroup is slightly better than Abraxane but with only a few patients in that group - not enough to have any statistical value. PPHM doesn't have enough money to do another 2nd line p2 or another pancreatic p2 and has to go for ATM. What do you think the share price would be?